Lynn A. Tetreault, a director at NeoGenomics Inc. ($NEO), made one open market purchase of company shares in the last year, totaling nearly $57,000. Her most recent buy occurred on May 9, 2025. This ranks her 2,858th among 4,983 insiders for purchase value, well below the average of $1.5 million across about 3.3 transactions per insider. She reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 30, 2025 | ALUMIS INC. | $ALMS | TETRAULT LYNN A. | Not found | A | Stock Option (Right to Buy) | 49800 | $0.00 | 49,800.0000 | 76,635,895 | 9999.99% | 0.06% |
| June 24, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | A | Stock Option (right to buy) | 7037 | $0.00 | 7,037.0000 | 63,059,165 | 9999.99% | 0.01% |
| June 24, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | A | Restricted Stock Units | 4712 | $0.00 | 4,712.0000 | 63,059,165 | 9999.99% | 0.01% |
| June 18, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Restricted Stock Units | 4000 | $0.00 | 0.0000 | 63,059,165 | 100.00% | 0.01% |
| June 18, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Common Stock | 4000 | $0.00 | 7,000.0000 | 63,059,165 | 133.33% | 0.01% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | M | Common Stock | 12254 | $0.00 | 80,652.0000 | 128,461,383 | 17.92% | 0.01% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | A | Restricted Stock Unit | 23077 | $0.00 | 23,077.0000 | 128,461,383 | 9999.99% | 0.02% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | A | Stock Option (Right to Buy) | 16107 | $0.00 | 33,132.0000 | 128,461,383 | 94.61% | 0.01% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | M | Restricted Stock Unit | 12254 | $0.00 | 0.0000 | 128,461,383 | 100.00% | 0.01% |
| May 9, 2025 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | P | Common Stock | 7000 | $8.14 | 68,398.0000 | 128,461,383 | 11.40% | 0.01% |
| Sept. 10, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | S | Common Stock | 8661 | $50.20 | 3,350.0000 | 61,011,824 | 72.11% | 0.01% |
| Sept. 10, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | S | Common Stock | 350 | $50.60 | 3,000.0000 | 61,011,824 | 10.45% | 0.00% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Stock Option (right to buy) | 3199 | $0.00 | 7,501.0000 | 61,011,824 | 29.90% | 0.01% |
| Sept. 10, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 61,011,824 | 100.00% | 0.02% |
| Sept. 10, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Stock Option (right to buy) | 7501 | $0.00 | 0.0000 | 61,011,824 | 100.00% | 0.01% |
| Sept. 10, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Common Stock | 10000 | $4.15 | 13,000.0000 | 61,011,824 | 333.33% | 0.02% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | S | Common Stock | 3199 | $50.04 | 3,000.0000 | 61,011,824 | 51.61% | 0.01% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Common Stock | 3199 | $18.99 | 6,199.0000 | 61,011,824 | 106.63% | 0.01% |
| Sept. 10, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | S | Common Stock | 8490 | $49.05 | 12,011.0000 | 61,011,824 | 41.41% | 0.01% |
| Sept. 10, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Common Stock | 7501 | $18.99 | 20,501.0000 | 61,011,824 | 57.70% | 0.01% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Common Stock | 4300 | $18.99 | 7,300.0000 | 61,011,824 | 143.33% | 0.01% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | S | Common Stock | 4300 | $50.01 | 3,000.0000 | 61,011,824 | 58.90% | 0.01% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Stock Option (right to buy) | 4300 | $0.00 | 10,700.0000 | 61,011,824 | 28.67% | 0.01% |
| Aug. 12, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | S | Common Stock | 9593 | $44.62 | 3,407.0000 | 61,011,824 | 73.79% | 0.02% |
| Aug. 12, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Common Stock | 10000 | $4.15 | 13,000.0000 | 61,011,824 | 333.33% | 0.02% |
| Aug. 12, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | S | Common Stock | 407 | $45.37 | 3,000.0000 | 61,011,824 | 11.95% | 0.00% |
| Aug. 12, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 61,011,824 | 50.00% | 0.02% |
| Aug. 10, 2024 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | M | Common Stock | 11336 | $0.00 | 61,398.0000 | 0 | 22.64% | 0.00% |
| Aug. 10, 2024 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | M | Restricted Stock Unit | 11336 | $0.00 | 12,254.0000 | 0 | 48.05% | 0.00% |
| June 21, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Restricted Stock Units | 3000 | $0.00 | 0.0000 | 60,143,558 | 100.00% | 0.00% |
| June 21, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | M | Common Stock | 3000 | $0.00 | 3,000.0000 | 60,143,558 | 9999.99% | 0.00% |
| June 18, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | A | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 60,143,558 | 9999.99% | 0.01% |
| June 18, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 60,143,558 | 9999.99% | 0.02% |
| June 1, 2024 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | A | Stock Option (Right to Buy) | 8672 | $0.00 | 17,025.0000 | 0 | 103.82% | 0.00% |
| June 1, 2024 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | A | Restricted Stock Unit | 12254 | $0.00 | 23,590.0000 | 0 | 108.10% | 0.00% |
| March 4, 2024 | NEOGENOMICS INC | $NEO | TETRAULT LYNN A. | Director | S | Common Stock | 6112 | $15.97 | 50,062.0000 | 0 | 10.88% | 0.00% |
| June 21, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 56,708,975 | 9999.99% | 0.02% |
| June 21, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | TETRAULT LYNN A. | Director | A | Restricted Stock Units | 3000 | $0.00 | 3,000.0000 | 56,708,975 | 9999.99% | 0.01% |